HETERO LABS LTD III FDA Approval ANDA 213513

ANDA 213513

HETERO LABS LTD III

FDA Drug Application

Application #213513

Application Sponsors

ANDA 213513HETERO LABS LTD III

Marketing Status

Over-the-counter001

Application Products

001TABLET;ORAL5MG0LEVOCETIRIZINE DIHYDROCHLORIDELEVOCETIRIZINE DIHYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-04-29STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213513
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVOCETIRIZINE DIHYDROCHLORIDE","activeIngredients":"LEVOCETIRIZINE DIHYDROCHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/29\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.